The exact diagnosis and treatment phase matter
A newly diagnosed leukemia, relapsed solid tumor and post-transplant complication require very different pathways. The reviewing team needs to know the current disease status and what treatment has already been given.
Stem-cell transplantation is highly diagnosis-specific
Freiburg describes allogeneic stem-cell transplantation for selected high-risk or relapsed leukemia and lymphoma, bone-marrow failure, immunodeficiencies and some metabolic diseases. Transplant is not a generic escalation step and depends on diagnosis, disease status, donor options and the expected balance of benefit and risk.
Supportive and family care matter
Pediatric cancer treatment can involve prolonged admissions, infection risk, nutrition, school disruption and psychosocial strain. International families should ask about parent accommodation, interpreter support, infection precautions and how follow-up will continue at home.
Records for a pediatric oncology second opinion
Send a complete chronological package.
- Pathology and molecular/genetic results
- Bone marrow reports when relevant
- Current and prior imaging
- Chemotherapy protocols and doses
- Radiotherapy details
- Operative reports
- Transplant or donor information if applicable
- Current blood counts, organ function and active complications
Official sources
Sources last checked 2026-08-29. Pediatric pathways can change and must be individualized; confirm current requirements directly with the treating pediatric center.